General Callout
Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.
Accordion
Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.
Heading 1
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Heading 2
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Call to action
Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate
Lonsurf (trifluridine/tipiracil)
Status:
Concluded with an LOI
Manufacturer:
Taiho Pharma Canada Inc.
Indication:
Metastatic Colorectal Cancer
Last updated August 8, 2019
Fibristal (ulipristal acetate)
Status:
Concluded with an LOI
Manufacturer:
Allergan Inc.
Indication:
Uterine fibroids (signs and symptoms)
Last updated August 6, 2019
Status:
Negotiations were not pursued
Manufacturer:
Takeda Canada Inc.
Indication:
Multiple Myeloma
Last updated August 2, 2019
Arbesda RespiClick (fluticasone propionate/salmeterol xinafoate)
Status:
Concluded without agreement
Manufacturer:
Teva Canada Ltd.
Indication:
Asthma
Last updated July 31, 2019
Aermony Respiclick (fluticasone propionate)
Status:
Concluded without agreement
Manufacturer:
Teva Canada Ltd.
Indication:
Asthma
Last updated July 31, 2019
Status:
Concluded with an LOI
Manufacturer:
Novo Nordisk Canada Inc.
Indication:
Diabetes Mellitus, Type 2
Last updated July 26, 2019
Status:
Concluded without agreement
Manufacturer:
Amgen Canada Inc.
Indication:
Primary hyperlipidemia and mixed dyslipidemia
Last updated July 25, 2019
Status:
Concluded with an LOI
Manufacturer:
Vertex Pharmaceuticals (Canada) Incorporated
Indication:
Cystic Fibrosis In Patients with CFTR Gating Mutations or the R117H Gating Mutation
Last updated July 17, 2019
Status:
Negotiations were not pursued
Manufacturer:
Ipsen Biopharmaceuticals Canada, Inc.
Indication:
Carcinoid Syndrome
Last updated July 12, 2019
Status:
Concluded with an LOI
Manufacturer:
Pfizer Canada ULC
Indication:
Rheumatoid Arthritis
Last updated July 9, 2019